SCHEMBL24574355

SCHEMBL24574355

FC1/C=C\CCCCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22526631 0.67
SCHEMBL19451112 0.67
SCHEMBL18818604 0.67 ALDH1A1 (0.53)
Cyclohexene SCHEMBL10886360 0.67 ALDH1A1 (0.53)
SCHEMBL718207 0.66
Piperidine SCHEMBL22115426 0.65 ALDH1A1 (0.60)
SCHEMBL20095228 0.65 ALDH1A1 (0.50)
SCHEMBL22854438 0.65 ALDH1A1 (0.60)
SCHEMBL18819101 0.65 ALDH1A1 (0.50)
SCHEMBL18710391 0.65 ALDH1A1 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023180485-A1 ANTIBODY-CONJUGATES FOR TARGETING OF TUMOURS EXPRESSING TROP-2 SYNAFFIX B.V. (NL) 2023-09-28 WO disclosed
WO-2022136705-A1 GLYCAN-CONJUGATED ANTIBODIES BINDING TO FC-GAMMA RECEPTOR SYNAFFIX B.V. (NL) 2022-06-30 WO disclosed